Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12,030 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A pilot study to evaluate a new combination therapy for gastric ulcer: Helicobacter pylori eradication therapy followed by gastroprotective treatment with rebamipide.
Terano A, Arakawa T, Sugiyama T, Yoshikawa T, Haruma K, Asaka M, Shimosegawa T, Sakaki N, Ishii H, Sakamoto C, Takahashi S, Kinoshita Y, Fujioka T, Kobayashi K. Terano A, et al. Among authors: kobayashi k. J Gastroenterol Hepatol. 2006 Jan;21(1 Pt 1):103-9. doi: 10.1111/j.1440-1746.2005.04191.x. J Gastroenterol Hepatol. 2006. PMID: 16706820 Clinical Trial.
Rebamipide, a gastro-protective and anti-inflammatory drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori in a Japanese population: a randomized, double-blind, placebo-controlled trial.
Terano A, Arakawa T, Sugiyama T, Suzuki H, Joh T, Yoshikawa T, Higuchi K, Haruma K, Murakami K, Kobayashi K; Rebamipide Clinical Study Group. Terano A, et al. Among authors: kobayashi k. J Gastroenterol. 2007 Aug;42(8):690-3. doi: 10.1007/s00535-007-2076-2. Epub 2007 Aug 24. J Gastroenterol. 2007. PMID: 17701133 Clinical Trial.
Effects of rebamipide, a gastro-protective drug on the Helicobacter pylori status and inflammation in the gastric mucosa of patients with gastric ulcer: a randomized double-blind placebo-controlled multicentre trial.
Fujioka T, Arakawa T, Shimoyama T, Yoshikawa T, Itoh M, Asaka M, Ishii H, Kuwayama H, Sato R, Kawai S, Takemoto T, Kobayashi K. Fujioka T, et al. Among authors: kobayashi k. Aliment Pharmacol Ther. 2003 Jul;18 Suppl 1:146-52. doi: 10.1046/j.1365-2036.18.s1.20.x. Aliment Pharmacol Ther. 2003. PMID: 12925153 Clinical Trial.
Peptic ulcer recurrence during maintenance therapy with H2-receptor antagonist following first-line therapy with proton pump inhibitor.
Kaneko E, Hoshihara Y, Sakaki N, Harasawa S, Ashida K, Asaka M, Asaki S, Nakamura T, Kobayashi K, Kajiyama G, Ogawa N, Yao T, Muto Y, Nakazawa S, Takemoto T. Kaneko E, et al. Among authors: kobayashi k. J Gastroenterol. 2000;35(11):824-31. doi: 10.1007/s005350070019. J Gastroenterol. 2000. PMID: 11085491 Clinical Trial.
12,030 results
You have reached the last available page of results. Please see the User Guide for more information.